Reshape Lifesciences Inc (STU:24O0)
€ 0.615 0 (0%) Market Cap: 3.67 Mil Enterprise Value: 2.59 Mil PE Ratio: 0 PB Ratio: 1.01 GF Score: 35/100

Q1 2022 ReShape Lifesciences Inc Earnings Call Transcript

May 23, 2022 / 12:30PM GMT
Release Date Price: €37.14 (-1.93%)
Operator

Good day, and thank you for standing by. Welcome to the ReShape Lifesciences First Quarter 2022 Earnings Webcast.

I would now like to hand the conference over to Michael Miller of Rx Communications. Please go ahead, sir.

Michael Miller

Good morning, and thank you for joining the ReShape Lifesciences First Quarter 2022 Earnings Webcast. I'm pleased to be joined by Bart Bandy, President and Chief Executive Officer of ReShape Lifesciences Inc., who will provide an overview of the company's activity during the first quarter and milestones to date. Tom Stankovich, Chief Financial Officer of ReShape, will then review the financial results for the quarter and then turn the call back over to Bart to finish.

As a reminder, this conference call as well as ReShape Lifesciences' SEC filings and website, including the Investor Information section of the website, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot